Auricular Stimulation Reduces Cardiac Postoperative AF Risk
By HospiMedica International staff writers Posted on 06 Nov 2019 |

Image: Graphical abstract of the study (Photo courtesy of Martin Andreas / MedUniWien).
A new study reveals that postoperative atrial fibrillation (POAF) complications could be halved by non-invasive electrical stimulation of the vagus nerve directly on the ear.
Researchers at the Medical University of Vienna (MedUniWien; Austria) conducted a randomized 1:1 study to examine the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in 40 patients slated for cardiac surgery. Following surgery, electrical stimulation electrodes were applied in the triangular fossa of the ear for up to two weeks. Heart rhythm was recorded continuously via Holter electrocardiogram (ECG), and C-reactive protein (CRP) and interleukin-6 plasma concentrations were measured.
The results revealed that the patients receiving LLTS (amplitude one mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) had a significantly reduced occurrence of POAF (4 of 20 events) when compared with the control group (11 of 20 events) during a similar mean Holter ECG recording period. The median duration of POAF was comparable between the treatment and the control group, and no effect of the LLTS application on CRP or IL-6 levels was detectable. The study was published on October 10, 2019, in Circulation: Arrhythmia and Electrophysiology.
“Electrical stimulation of the ear and the vagus nerve that sits on the surface there has a calming effect, in that we are stimulating the largest nerve of the parasympathetic nervous system and hence the corresponding antagonists,” said lead author Martin Andreas, MD, PhD, of the department of surgery. “This stimulation is given continuously in the first five days after an operation, when the risk of POAF is at its highest, and is then stopped, if everything goes well. The innovative product, from an Austrian company from Mauerbach, has already been successfully used for vascular occlusions.”
POAF occurs in up to 40% of patients undergoing cardiac surgery. Conventional viewpoints suggest that it is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is also associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.
Related Links:
Medical University of Vienna
Researchers at the Medical University of Vienna (MedUniWien; Austria) conducted a randomized 1:1 study to examine the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in 40 patients slated for cardiac surgery. Following surgery, electrical stimulation electrodes were applied in the triangular fossa of the ear for up to two weeks. Heart rhythm was recorded continuously via Holter electrocardiogram (ECG), and C-reactive protein (CRP) and interleukin-6 plasma concentrations were measured.
The results revealed that the patients receiving LLTS (amplitude one mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) had a significantly reduced occurrence of POAF (4 of 20 events) when compared with the control group (11 of 20 events) during a similar mean Holter ECG recording period. The median duration of POAF was comparable between the treatment and the control group, and no effect of the LLTS application on CRP or IL-6 levels was detectable. The study was published on October 10, 2019, in Circulation: Arrhythmia and Electrophysiology.
“Electrical stimulation of the ear and the vagus nerve that sits on the surface there has a calming effect, in that we are stimulating the largest nerve of the parasympathetic nervous system and hence the corresponding antagonists,” said lead author Martin Andreas, MD, PhD, of the department of surgery. “This stimulation is given continuously in the first five days after an operation, when the risk of POAF is at its highest, and is then stopped, if everything goes well. The innovative product, from an Austrian company from Mauerbach, has already been successfully used for vascular occlusions.”
POAF occurs in up to 40% of patients undergoing cardiac surgery. Conventional viewpoints suggest that it is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is also associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.
Related Links:
Medical University of Vienna
Latest Critical Care News
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more